The Advocacy Lab

In this episode, Cheryl-Anne Simoneau sits down with Teresa Norris, President & Founder of HPV Global Action and President of the Coalition Priorité Cancer du Québec, for a conversation about HPV that everyone needs to hear.
Did you know that oropharyngeal cancers in men are now surpassing cervical cancer in women — and that there is no test available for men to detect HPV? The good news is that the HPV vaccine, which can prevent at least 9 types of cancer, has no upper age limit and can be prescribed and administered by your local pharmacist today.
For more information visit HPV Global Action at www.hpvglobalaction.org

Dans cet épisode, Cheryl-Anne Simoneau s'entretient avec Teresa Norris, spécialiste en santé sexuelle, présidente et fondatrice de HPV Global Action et présidente de la Coalition Priorité Cancer du Québec.
Teresa nous explique tout ce que nous devons savoir sur le virus du papillome humain (VPH) — un virus qui peut rester dormant dans l'organisme pendant près de 40 ans. Elle nous parle également du vaccin contre le VPH, l'un des premiers vaccins de l'histoire capable de prévenir au moins 9 types de cancer. Et surtout — ce vaccin n'est pas seulement pour les femmes. Les hommes doivent aussi se faire vacciner, et il n'y a pas de limite d'âge supérieure pour la vaccination.
Une conversation essentielle pour tout le monde.

What happens when a patient uses AI to advocate for herself — and it changes the course of her diagnosis?
In our latest episode, I speak with Alvina Nadeem, an ovarian cancer survivor whose story shows how technology, persistence, and lived experience can intersect in powerful ways.
 

This podcast explores what happens when patients don’t just survive disease — they change the science AND Policies around it.
In this first episode, I’m joined by Dr. Suzan McNamara. When treatment options for chronic myeloid leukemia were running out, Suzan refused to accept that silence was the answer. She helped launch a patient petition that changed access — and then went on to earn a PhD studying resistance in leukemia.